Hepatitis B
Hepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide. The World Health O...
Gespeichert in:
| Veröffentlicht in: | Drug and alcohol review 1996-09, Vol.15 (3), p.289-305 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 305 |
|---|---|
| container_issue | 3 |
| container_start_page | 289 |
| container_title | Drug and alcohol review |
| container_volume | 15 |
| creator | Batey, R.G. Bollipo, S.J. |
| description | Hepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide. The World Health Organization has suggested that universal vaccination of children against hepatitis B should be implemented in an attempt to reduce the enormous morbidity and mortality associated with infection of this virus group. The review seeks to identify all the newer discoveries relating to hepatitis B that have been made in the past decade. Reference is made to the appearance of hepatitis B mutants which are able to infect patients previously infected with the wild strain of the virus. The implications of mutants on vaccination programmes is raised, as are issues relating to treatment of hepatitis B infection. |
| doi_str_mv | 10.1080/09595239600186031 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_infor</sourceid><recordid>TN_cdi_informahealthcare_journals_10_1080_09595239600186031</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><informt_id>10.3316/ielapa.970807927</informt_id><sourcerecordid>57399793</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5589-bf75ca1ef7e598b9fdae509489526e12159b0a79743a2167a29b22ec5f08c3b93</originalsourceid><addsrcrecordid>eNqFkU1vEzEQhi0EomngB3BBnLht8ceO7RGnUkiLFBWEQHAbeTde4rLJbm1H0H-P043ggEROPszzPh69w9gzwc8Et_wVR0CQCjXnwmquxAM2E7WGSiktH7LZfl4VQJ-w05RuOOcSQD5mJ0JLrpStZ2x-5UeXQw7pxZsn7FHn-uSfHt45-7J49_niqlp-uHx_cb6sWgCLVdMZaJ3wnfGAtsFu5TxwrG3ZRXshBWDDnUFTKyeFNk5iI6VvoeO2VQ2qOXs5ecc43O58yrQJqfV977Z-2CUy1mgNGo6CYBSiQXUUFKAtSl4XUExgG4eUou9ojGHj4h0JTvtO6Z9OS-b5Qb5rNn71N3EosQAwAT9D7--OG-nt-ae63vewmHJxEzK50XWZ1jmPiVYuOwrbbrifDPE7rYawFyolNAXfF5jQFLtBaYqomkQhZf_rzwIu_iBtlAH6en1JwK8_LuViQd8K__rA33_h1t71ed266Olm2MVtOf5_-vgNUS62tQ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>15689204</pqid></control><display><type>article</type><title>Hepatitis B</title><source>Applied Social Sciences Index & Abstracts (ASSIA)</source><source>Access via Taylor & Francis</source><creator>Batey, R.G. ; Bollipo, S.J.</creator><creatorcontrib>Batey, R.G. ; Bollipo, S.J.</creatorcontrib><description>Hepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide. The World Health Organization has suggested that universal vaccination of children against hepatitis B should be implemented in an attempt to reduce the enormous morbidity and mortality associated with infection of this virus group. The review seeks to identify all the newer discoveries relating to hepatitis B that have been made in the past decade. Reference is made to the appearance of hepatitis B mutants which are able to infect patients previously infected with the wild strain of the virus. The implications of mutants on vaccination programmes is raised, as are issues relating to treatment of hepatitis B infection.</description><identifier>ISSN: 0959-5236</identifier><identifier>EISSN: 1465-3362</identifier><identifier>DOI: 10.1080/09595239600186031</identifier><identifier>PMID: 16203384</identifier><language>eng</language><publisher>Oxford, UK: Informa UK Ltd</publisher><subject>Antiviral drugs ; Cancer ; cirrhosis ; Clinical features ; Diseases ; Drugs (Pharmaceuticals) ; Epidemiology ; Hepatitis B ; hepatitis B virus ; hepatitis viruses ; hepatocellular carcinoma ; Immunisation ; immunization ; Literature reviews ; Medicine ; Mutant strains ; prevention strategies ; Public health ; Therapy ; Transmission ; Virology</subject><ispartof>Drug and alcohol review, 1996-09, Vol.15 (3), p.289-305</ispartof><rights>1996 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted 1996</rights><rights>1996 Australasian Professional Society on Alcohol and other Drugs</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5589-bf75ca1ef7e598b9fdae509489526e12159b0a79743a2167a29b22ec5f08c3b93</citedby><cites>FETCH-LOGICAL-c5589-bf75ca1ef7e598b9fdae509489526e12159b0a79743a2167a29b22ec5f08c3b93</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.tandfonline.com/doi/pdf/10.1080/09595239600186031$$EPDF$$P50$$Ginformahealthcare$$H</linktopdf><linktohtml>$$Uhttps://www.tandfonline.com/doi/full/10.1080/09595239600186031$$EHTML$$P50$$Ginformahealthcare$$H</linktohtml><link.rule.ids>314,780,784,27924,27925,31000,61221,61402</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16203384$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Batey, R.G.</creatorcontrib><creatorcontrib>Bollipo, S.J.</creatorcontrib><title>Hepatitis B</title><title>Drug and alcohol review</title><addtitle>Drug Alcohol Rev</addtitle><description>Hepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide. The World Health Organization has suggested that universal vaccination of children against hepatitis B should be implemented in an attempt to reduce the enormous morbidity and mortality associated with infection of this virus group. The review seeks to identify all the newer discoveries relating to hepatitis B that have been made in the past decade. Reference is made to the appearance of hepatitis B mutants which are able to infect patients previously infected with the wild strain of the virus. The implications of mutants on vaccination programmes is raised, as are issues relating to treatment of hepatitis B infection.</description><subject>Antiviral drugs</subject><subject>Cancer</subject><subject>cirrhosis</subject><subject>Clinical features</subject><subject>Diseases</subject><subject>Drugs (Pharmaceuticals)</subject><subject>Epidemiology</subject><subject>Hepatitis B</subject><subject>hepatitis B virus</subject><subject>hepatitis viruses</subject><subject>hepatocellular carcinoma</subject><subject>Immunisation</subject><subject>immunization</subject><subject>Literature reviews</subject><subject>Medicine</subject><subject>Mutant strains</subject><subject>prevention strategies</subject><subject>Public health</subject><subject>Therapy</subject><subject>Transmission</subject><subject>Virology</subject><issn>0959-5236</issn><issn>1465-3362</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1996</creationdate><recordtype>article</recordtype><sourceid>7QJ</sourceid><recordid>eNqFkU1vEzEQhi0EomngB3BBnLht8ceO7RGnUkiLFBWEQHAbeTde4rLJbm1H0H-P043ggEROPszzPh69w9gzwc8Et_wVR0CQCjXnwmquxAM2E7WGSiktH7LZfl4VQJ-w05RuOOcSQD5mJ0JLrpStZ2x-5UeXQw7pxZsn7FHn-uSfHt45-7J49_niqlp-uHx_cb6sWgCLVdMZaJ3wnfGAtsFu5TxwrG3ZRXshBWDDnUFTKyeFNk5iI6VvoeO2VQ2qOXs5ecc43O58yrQJqfV977Z-2CUy1mgNGo6CYBSiQXUUFKAtSl4XUExgG4eUou9ojGHj4h0JTvtO6Z9OS-b5Qb5rNn71N3EosQAwAT9D7--OG-nt-ae63vewmHJxEzK50XWZ1jmPiVYuOwrbbrifDPE7rYawFyolNAXfF5jQFLtBaYqomkQhZf_rzwIu_iBtlAH6en1JwK8_LuViQd8K__rA33_h1t71ed266Olm2MVtOf5_-vgNUS62tQ</recordid><startdate>199609</startdate><enddate>199609</enddate><creator>Batey, R.G.</creator><creator>Bollipo, S.J.</creator><general>Informa UK Ltd</general><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7QJ</scope><scope>7X8</scope></search><sort><creationdate>199609</creationdate><title>Hepatitis B</title><author>Batey, R.G. ; Bollipo, S.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5589-bf75ca1ef7e598b9fdae509489526e12159b0a79743a2167a29b22ec5f08c3b93</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1996</creationdate><topic>Antiviral drugs</topic><topic>Cancer</topic><topic>cirrhosis</topic><topic>Clinical features</topic><topic>Diseases</topic><topic>Drugs (Pharmaceuticals)</topic><topic>Epidemiology</topic><topic>Hepatitis B</topic><topic>hepatitis B virus</topic><topic>hepatitis viruses</topic><topic>hepatocellular carcinoma</topic><topic>Immunisation</topic><topic>immunization</topic><topic>Literature reviews</topic><topic>Medicine</topic><topic>Mutant strains</topic><topic>prevention strategies</topic><topic>Public health</topic><topic>Therapy</topic><topic>Transmission</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Batey, R.G.</creatorcontrib><creatorcontrib>Bollipo, S.J.</creatorcontrib><collection>Istex</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Applied Social Sciences Index & Abstracts (ASSIA)</collection><collection>MEDLINE - Academic</collection><jtitle>Drug and alcohol review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Batey, R.G.</au><au>Bollipo, S.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Hepatitis B</atitle><jtitle>Drug and alcohol review</jtitle><addtitle>Drug Alcohol Rev</addtitle><date>1996-09</date><risdate>1996</risdate><volume>15</volume><issue>3</issue><spage>289</spage><epage>305</epage><pages>289-305</pages><issn>0959-5236</issn><eissn>1465-3362</eissn><abstract>Hepatitis B remains a major public health problem around the world. The discovery of the hepatitis C virus has diverted interest from hepatitis B to this new virus and the epidemic associated with it, but hepatitis B remains a significant pathogen for millions of people worldwide. The World Health Organization has suggested that universal vaccination of children against hepatitis B should be implemented in an attempt to reduce the enormous morbidity and mortality associated with infection of this virus group. The review seeks to identify all the newer discoveries relating to hepatitis B that have been made in the past decade. Reference is made to the appearance of hepatitis B mutants which are able to infect patients previously infected with the wild strain of the virus. The implications of mutants on vaccination programmes is raised, as are issues relating to treatment of hepatitis B infection.</abstract><cop>Oxford, UK</cop><pub>Informa UK Ltd</pub><pmid>16203384</pmid><doi>10.1080/09595239600186031</doi><tpages>17</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0959-5236 |
| ispartof | Drug and alcohol review, 1996-09, Vol.15 (3), p.289-305 |
| issn | 0959-5236 1465-3362 |
| language | eng |
| recordid | cdi_informahealthcare_journals_10_1080_09595239600186031 |
| source | Applied Social Sciences Index & Abstracts (ASSIA); Access via Taylor & Francis |
| subjects | Antiviral drugs Cancer cirrhosis Clinical features Diseases Drugs (Pharmaceuticals) Epidemiology Hepatitis B hepatitis B virus hepatitis viruses hepatocellular carcinoma Immunisation immunization Literature reviews Medicine Mutant strains prevention strategies Public health Therapy Transmission Virology |
| title | Hepatitis B |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T15%3A47%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_infor&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Hepatitis%20B&rft.jtitle=Drug%20and%20alcohol%20review&rft.au=Batey,%20R.G.&rft.date=1996-09&rft.volume=15&rft.issue=3&rft.spage=289&rft.epage=305&rft.pages=289-305&rft.issn=0959-5236&rft.eissn=1465-3362&rft_id=info:doi/10.1080/09595239600186031&rft_dat=%3Cproquest_infor%3E57399793%3C/proquest_infor%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=15689204&rft_id=info:pmid/16203384&rft_informt_id=10.3316/ielapa.970807927&rfr_iscdi=true |